Exicure, Inc. Profile Avatar - Palmy Investing

Exicure, Inc.

Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic…

Biotechnology
US, Chicago [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Exicure, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Exicure, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Exicure, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of XCUR's Analysis
CIK: 1698530 CUSIP: 30205M101 ISIN: US30205M2008 LEI: - UEI: -
Secondary Listings
XCUR has no secondary listings inside our databases.